Kenneth Hugh Mayer

Professor in the Department of Global Health and Population

Global Health and Population, Harvard T.H. Chan School of Public Health

Departments

Department of Global Health and Population

Other Positions

Professor of Medicine

;Medicine-Beth Israel Deaconess, Harvard Medical School

Biography

Kenneth's Catalyst Profile

Publications

Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study.

Cooney EE, Stevenson M, Aguayo-Romero RA, Valera G, Poteat TC, Mayer KH, Beyrer C, Althoff KN, Radix AE, Wawrzyniak AJ, Cannon CM, Schneider JS, Brown CA, Vannappagari V, Ragone L, de Ruiter A, Reisner SL, Wirtz AL. AIDS Behav 2024 Dec 05
Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era.

Ma J, Delaney JAC, Ruderman SA, Nance RM, Hahn AW, Drumright LN, Whitney BM, Fredericksen RJ, Mixson LS, Merrill JO, Safren SA, Mayer KH, O'Cleirigh C, Napravnik S, Chander G, Moore RD, Christopoulos KA, Willig AL, Bamford L, Webel A, McCaul ME, Cachay ER, Jacobson JM, Saag MS, Kitahata MM, Crane HM, Williams EC. AIDS Behav 2024 Dec 03
Disparities in depression and anxiety at the intersection of race and gender identity in a large community health sample.

Stanton AM, Chiu C, Dolotina B, Kirakosian N, King DS, Grasso C, Potter J, Mayer KH, O'Cleirigh C, Batchelder AW. Soc Sci Med 2024 Nov 30
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O. N Engl J Med 2024 Nov 27
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF, Jennings A, Gomez-Feliciano K, McCauley M, Grinsztejn B, Landovitz RJ. Clin Infect Dis 2024 Nov 23

View more publications

Unleash your potential at Harvard Chan School.

In addition to our degree programs, we offer highly targeted executive and continuing education, directed and taught by Harvard faculty.

Degree Programs

How to Apply

Executive and Continuing Education

Biography

Publications

Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study.

Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era.

Disparities in depression and anxiety at the intersection of race and gender identity in a large community health sample.

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.

Unleash your potential at Harvard Chan School.